SWHC: Smith and Wesson is money in the bank short of market crash. If you’re not long yet I’d start a small position before it sees $10. I’m thinking $15 as a target.

NSPH: Is up over 100% since I mentioned it just a few weeks ago. http://ibankcoin.com/henryfools/2012/06/27/dont-nanosize-your-nsph-breakout-buy/ However I still like It’s upward potential. The June FDA approval of Nanosphere’s (NASDAQ:NSPH) bloodstream infection test, and subsequent jump in shares has prompted Roth Capital to upgrade from Neutral to Buy, with a price target of $4.50. Jefferies upgraded to stock last week for much the same reasons. Just look at the historical perspective. As well look at the historical chart on NSPH. Not only was this double digits, but the volume was bupkis above the current price. Hence there should be little resistance on further gains.

JMBA: Jamba Juice is finally squeezing profits out. With profits come positive estimates, estimate revisions, value chasing. Once again, from my perspective we should probably take the companies most recent qtr, as well as their 100% yoy upward revision to same store sales to 4% from 2%. to mean time to apply a 2 PEG or 50 PE to the highest current estimate of .18= $9.00 bucks!  Maybe a little over zealous a target for a trade but you get my point.  Nice channel breakout, also volume is strong!

WATCH LIST   OME, THLD, LF, PATK, and more.

Tweet